Company intelligence / Profile preview
Kernal Biologics
Cambridge, Massachusetts, United Stateskernalbio.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
Kernal Biologics has developed a proprietary “mRNA 2.0” platform for creating onco-selective and cell-targeted mRNA therapies. Their lead programs are preclinical, with the most advanced candidate preparing for IND submission in immuno-oncology. Early data highlight high delivery efficiency (>90% to T-cells) and rapid B-cell depletion using in vivo CAR-T programming technology[2][4]. No clinical trial results have been published yet.
- Therapeutic areas
- OncologyImmunology
- Modalities
- mRNA therapeuticsmRNA-LNP (lipid nanoparticle) immunotherapiesGene therapy approaches (in vivo CAR-T programming)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Amgen Ventures is an investor; no major pharma development partnerships disclosed yet[7].
Beyond the preview
Go deeper on Kernal Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kernal Biologics.